27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Immunic (NASDAQ:IMUX) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Immunic beat estimated earnings by 7.5%, reporting an EPS of $-0.74 versus an estimate of $-0.8.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 0.28% drop in the share price the next day.
To track all earnings releases for Immunic visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!